Malin Corporation | MLC - Equity Capital And Reserves


Malin Corporation reported EUR193.2M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 25.02M 2.36M Jun/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
ALKERMES USD 1.81B 57.02M Jun/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Eurofins Scientific SE EUR 3.62B 76M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Lonza CHF 9.13B 513M Dec/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 6.76B 647M Jun/2026
Organon & Co USD 903M 151M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Revvity USD 7.18B 67.62M Mar/2026
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026